Survivin overexpression has been associated with poor prognosis in several cancers, including gliomas, renal cell carcinoma, esophageal cancer, breast cancer, gastric cancer, ovarian cancer, laryngeal cancer, and colorectal cancer [37,38,39,40,41,42,43,44]. This evidence concerns the gene BIRC5 and cancer.